Many men are at risk from prostate cancer. This form of cancer will affect one man in every six during their lifetime. The death rate from prostate cancer is one man in every thirty five. Over one hundred and ninety thousand men in the United States of America will be diagnosed with this cancer each year. More than twenty seven thousand men will die of the disease each year in the USA. This can be avoided.

Men who are most at risk are those who are genetically prone to cancer of the prostate. Men who carry a variant of the COX-2 gene are known to be more prone to prostate cancer than other men. However studies have shown that an increase of Omega 3 fatty acids in the diet can reduce the probability of contracting cancer of the prostate.

Some men are more susceptible to prostate cancer because of their lifestyle. Being overweight and smoking are two factors that increase the possibility of developing cancer of the prostate. By changing their lifestyle and diet these men can also reduce the probability of this form of cancer. Read more…

Ovarian cancer is known to be a silent killer. It takes the lives of close to 15,000 women across the United States each year and is usually difficult to detect. It is the leading cause of death among gynaecological cancers and the fifth among cancers of all kind. Much of the problem in providing adequate and fast treatment comes from the fact that it displays no tell-tale ovarian cancer symptoms to go by. Often enough, screening for cancer can fail at the first attempt and require multiple tests to provide a true positive result.

Other than that, the early stages are very similar to other gynaecological problems that women display and are usually treated for the same. It can also be wrongly diagnosed as Irritable Bowel Syndrome and treated for that, further postponing correct therapy for cancer. Read more…

Testicular cancer is also known as germ cell tumor and is of two kinds – seminoma or nonseminoma. About 40% of testicular cancer are seminoma type and the other are divided into four sub-types; choriocarcinoma, teratoma, embryonal carcinoma and yolk sac tumors. The cancer can sometimes also be a combination of both cancers, and are called mixed germ-cell tumors.

Other testicular cancer symptoms to be on the lookout for are loss of sexual appetite, buildup of fluid in the scrotum and pain or tenderness in the testicles. To be sure, testicular cancer isn’t something that is on the tip of most people’s tongue. Still, it is something that people need to be aware of. Nobody is immune from it, as champion Lance Armstrong proved when he almost died as a result of the condition. Read more…

A routine breast examination is advised for all women to identify any suspicious lumps so that breast cancer detection is made as early as possible. Mammography is the most common first line screening tool for breast cancer. But in some cases, mammography may miss some abnormalities, especially if the woman’s breast tissue is dense. Sometimes dense breast tissue and cancers may appear similar in mammography.

So, a lump that may be felt manually may appear as normal breast tissue when screened through mammography which may then lead to a biopsy to confirm cancer. But now, even the cancerous tissue that mammography misses can be identified by a new diagnostic technique called breast specific gamma imaging.

This is different from mammography, sonography or MRI. The imaging in breast specific gamma imaging is not anatomical, but functional. It is also much superior to traditional screening methods because gamma imaging picks up cells that are beginning to act cancerous even before the abnormality becomes advanced enough to be visible on a mammogram or a sonogram. Read more…

Cancer is a deadly disease all over the world, with very little known about curing it completely. One type of cancer that affects many women around the world is ovarian cancer.

It has now become the fifth leading cause of death in cancer patients and leads the charts under all the gynaecological cancer deaths. Women of all demographics, races and ethnicities show risk factors for developing ovarian cancer. After one has been diagnosed with ovarian cancer, the first response is to affirm the ovarian cancer survival rates and life expectancy. These rates differ from patient to patient, but some common factors are the age, family history of disease and early diagnoses of the cancer. Read more…

Conventional Mesothelioma cancer treatment consists mainly of three main options- surgery, chemotherapy, or radiation.

Newer medical therapies that are been discovered include the use of more targeted therapies that address the biological factors triggering mesothelioma growth might be a much more precise and effective way to combat this notoriously difficult cancer.

Mesothelioma is so difficult to treat properly because most often by the time it is diagnosed it is already in an advanced stage, and because it can take many biological forms. Current mesothelioma treatments were originally designed for other types of cancers, without considering factors that may be specific to mesothelioma. That may be why many patients only partially respond to treatment, and the average survival is just 12 months after diagnosis. Read more…

Committed to making a difference in the world around them, BBYO teen leaders will be working hand-in-hand with Congresswoman Debbie Wasserman Shultz’s (D- FL) office to support her proposed bill, The EARLY Act—legislation advocating breast cancer awareness and early detection education. Through a series of awareness campaigns and events, BBYO will make The EARLY Act an integral part of its service and advocacy agenda through its new Stand Up for Those in Need Campaign.

The EARLY Act provides BBYO teens hands-on experience with real policy work on an issue that is vitally important, particularly due to the increased risk for the disease in Jewish women. Througout the year, several national initiatives will take place such as: Read more…

Most people have some concerns about taking part in a clinical trial, often because they’re not really sure what it will mean for them. Taking time to get as much information as you need before you decide is the best way to be sure that you will make the choice that is right for you. These are the commonly asked questions about mesothelioma clinical trials:

1- Is the clinical trial risky?

Yes, all clinical trials have risks. Every medical test, drug, or procedure has risks. The risk may be greater in a clinical trial because some aspects of any new treatment are unknown. This is especially true of phase I and II clinical trials, where the treatment has been studied in fewer people.

Perhaps a more important question is whether the risks are outweighed by the possible benefits. Since mesothelioma cancer is often a terminal disease with the current treatment modalities offering little hope in terms of cure, most victims are often willing to accept a certain amount of risk for a chance to be helped, but it is always important to be realistic about what this chance is. Ask your doctor to give you an idea of what the possible benefits are, and exactly what benefit is likely for you. Read more…

Since you have only one chance to report simulation per treatment course, you should nab the right code the very first time by focusing on the number of ports, treatment volumes and treatment devices.

You can choose four simulation codes from the CPT basket:

Ovarian cancer is deemed to be the most deadly gynaecological cancer and is the fifth leading cause of cancer related deaths is the United States. Claiming close to some 15,000 lives each year, it is one form of cancer difficult to recognize because it displays no symptoms till it has advanced to a very high level. Ovarian cancer stages are dependent on the size and spread of the tumor inside the body.

The further treatment of ovarian cancer is dependent on which stage it has progressed to. To classify stages, doctors take help of a simple rating system from 1 to 4. Stage I is the lowest on scale whereas Stage IV is close to being fatal and is the highest on the scale. Other than that, there are also borderline tumors. Read more…